Senseonics Holdings, Inc. (SENS) vs ARS Pharmaceuticals, Inc. (SPRY)
A side-by-side comparison of Senseonics Holdings, Inc. and ARS Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
SENS
Senseonics Holdings, Inc.
$9.90HealthcareDelayed quote: Oct 6, 2026, 2:40 PM EDT
SPRY
ARS Pharmaceuticals, Inc.
$4.28HealthcareDelayed quote: Oct 6, 2026, 2:40 PM EDT
Total return — SENS vs SPRY
growth of $100 · dividends reinvested · last 6ySENS +33.5% (+4.9%/yr)SPRY -82.8% (-25.5%/yr)SENS compounded faster over this window
Log scale — wide-divergence pair
SENS SPRY
SENS vs SPRY: by the numbers
- •SPRY is the larger company ($425M vs $414M market cap).
- •Both run net losses; SPRY's is the smaller (-184.24% vs -225.34% net margin).
- •SPRY grew revenue faster over the past five years (36.43% vs 35.10% CAGR).
Metrics side by side
Valuation
| Metric | SENS | SPRY |
|---|---|---|
| P/S ratio | 8.52 | 3.63 |
| P/B ratio | 4.58 | 33.93 |
Profitability
| Metric | SENS | SPRY |
|---|---|---|
| Gross margin | 44.71% | 73.89% |
| Operating margin | -193.83% | -212.92% |
| Net margin | -225.34% | -184.24% |
| ROE | -121.12% | -1721.80% |
| ROIC | -71.22% | -114.65% |
Growth (annualized)
| Metric | SENS | SPRY |
|---|---|---|
| Revenue CAGR (5Y) | 35.10% | 36.43% |
| Total return CAGR (5Y) | -30.89% | -16.35% |
Frequently asked
- Which has grown faster, SENS or SPRY?
- Over the past five years, SPRY grew revenue faster — SENS at a 35.10% CAGR versus SPRY at 36.43%.
- How have SENS and SPRY total returns compared?
- Over the past 5 years, SENS delivered -30.89% and SPRY delivered -16.35% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Senseonics ROEARS Pharmaceuticals ROESenseonics operating marginARS Pharmaceuticals operating marginSenseonics revenue growthARS Pharmaceuticals revenue growthSenseonics free cash flowARS Pharmaceuticals free cash flow
Senseonics & ARS Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.